arrow
Back
H

Helen Stacey

laval university

6H-index
11Paper Count
279Citation Count
Published Papers 5
Publication Date
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age
err2025-02-05
err0
errOAAI
errNeutel, Joel M.; Erdem, Rahsan; Jiang, Qin; Cannon, Kevin; Stacey, Helen; Newton, Ryan; Gomme, Emily; Li, Wen; Mensa, Federico J.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Munjal, Iona; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S.; Gurtman, Alejandra; Kitchin, Nicholas
errShare
errSave
A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6)
err2024-07-31
err8
errOAAI
errScott, Paul; Haranaka, Miwa; Choi, Jung Hyun; Stacey, Helen; Dionne, Marc; Greenberg, David; Grijalva, Carlos G.; Orenstein, Walter A.; Fernsler, Doreen; Gallagher, Nancy; Zeng, Tiantian; Li, Jianing; Platt, Heather L.
errShare
errSave
Safety and tolerability of KAN-101, a liver-targeted immune tolerance therapy, in patients with coeliac disease (ACeD): a phase 1 trial
err2023-08-01
err25
PREAI
errMurray, Joseph A.; Wassaf, Dina; Dunn, Karen; Arora, Samir; Winkle, Peter; Stacey, Helen; Cooper, Simon; Goldstein, Kaela E.; Manchanda, Rajesh; Kontos, Stephan; Grebe, Kristie M.
errShare
errSave
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
err2019-01-16
err88
errOAAI
errStacey, Helen L.; Rosen, Jeffrey; Peterson, James T.; Williams-Diaz, Angela; Gakhar, Vanita; Sterling, Tina M.; Acosta, Camilo J.; Nolan, Katrina M.; Li, Jianing; Pedley, Alison; Benner, Patrice; Abeygunawardana, Chitrananda; Kosinski, Michael; Smith, William J.; Pujar, Hari; Musey, Luwy K.
errShare
errSave
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
err2018-11-14
err39
errOAAI
errPeterson, James T.; Stacey, Helen L.; MacNair, John E.; Li, Jianing; Hartzel, Jonathan S.; Sterling, Tina M.; Benner, Patrice; Tamms, Gretchen M.; Musey, Luwy K.
errShare
errSave